Theralase Technologies (CVE:TLT) Stock Price Down 8%

Shares of Theralase Technologies Inc. (CVE:TLT) were down 8% during trading on Tuesday . The company traded as low as C$0.34 and last traded at C$0.35, approximately 400,193 shares changed hands during trading. An increase of 70% from the average daily volume of 235,043 shares. The stock had previously closed at C$0.38.

The company has a debt-to-equity ratio of 0.95, a current ratio of 19.66 and a quick ratio of 18.27. The firm has a market capitalization of $75.41 million and a P/E ratio of -9.58. The company’s 50-day simple moving average is C$0.29 and its two-hundred day simple moving average is C$0.29.

Theralase Technologies Company Profile (CVE:TLT)

Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. It operates in two divisions, Photo Dynamic Therapy and Therapeutic Laser Technology.

Read More: Why do earnings reports matter?

Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with's FREE daily email newsletter.